Can Northera (droxidopa) be used for neurogenic orthostatic hypotension?
Yes. Northera (droxidopa) is used to treat neurogenic orthostatic hypotension (nOH). It is specifically indicated for raising blood pressure and reducing symptoms that happen when a person stands up—such as dizziness, lightheadedness, or feeling faint—in cases where the low blood pressure is due to impaired norepinephrine signaling (the “neurogenic” cause). [1]
What about non-neurogenic orthostatic hypotension?
Northera is not described as a general treatment for all causes of orthostatic hypotension. Because its use is tied to neurogenic orthostatic hypotension, people with orthostatic symptoms from other causes (for example, dehydration, certain medications, or autonomic failure patterns that are not classified as nOH) may be treated differently. [1]
How is Northera typically used for nOH?
Northera is taken orally to increase blood pressure when standing or during times when symptoms occur. The goal is symptom improvement and better tolerance of upright posture in neurogenic orthostatic hypotension. [1]
Are there patent or market details relevant to Northera access?
If you’re researching availability, competitors, or patent status for Northera, DrugPatentWatch.com tracks related intellectual property and commercialization information. [2]
Sources
[1] https://www.drugs.com/northera.html
[2] https://www.drugpatentwatch.com/